• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cynapsus Therapeutics Inc

+ Add to Watchlist

CYNAF:US

0.8990 USD 0.0120 1.32%

As of 20:10:05 ET on 12/19/2014.

Snapshot for Cynapsus Therapeutics Inc (CYNAF)

Open: 0.9100 Day's Range: 0.8890 - 0.9170 Volume: 89,621
Previous Close: 0.9110 52wk Range: 0.4000 - 1.3850 1-Yr Rtn: +131.89%

Stock Chart for CYNAF

No chart data available.
  • CYNAF:US 0.8990
  • 1D
  • 1M
  • 1Y
0.9110
Interactive CYNAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYNAF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -0.1400
Est. PEG Ratio -
Market Cap (M USD) 71.52
Shares Outstanding (M) 79.56
30 Day Average Volume 352,976
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYNAF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for CYNAF

Cynapsus Therapeutics, Inc. researches and develops pharmaceuticals. The Company researches treatments for Parkinson's disease, neuropathic pain associated with multiple sclerosis and cancer, and nausea and vomiting and appetite stimulation.

Anthony J GiovinazzoPresident/CEOAndrew Michael WilliamsCFO/COO
Thierry BilbaultExec VP:CMC/Chief Scientific Ofcr
More Company Profile & Key Executives for CYNAF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil